Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-045731
Filing Date
2025-03-27
Accepted
2025-03-27 07:30:27
Documents
99
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K svra-20241231.htm   iXBRL 10-K 2737788
2 EX-10.38 svra-ex10_38.htm EX-10.38 215777
3 EX-10.39 svra-ex10_39.htm EX-10.39 214025
4 EX-10.40 svra-ex10_40.htm EX-10.40 199992
5 EX-10.41 svra-ex10_41.htm EX-10.41 143249
6 EX-23.1 svra-ex23_1.htm EX-23.1 4018
7 EX-31.1 svra-ex31_1.htm EX-31.1 15261
8 EX-31.2 svra-ex31_2.htm EX-31.2 15339
9 EX-32.1 svra-ex32_1.htm EX-32.1 13330
10 GRAPHIC img199040218_0.jpg GRAPHIC 5538
11 GRAPHIC img199040218_1.jpg GRAPHIC 111512
12 GRAPHIC img199040218_2.jpg GRAPHIC 267225
13 GRAPHIC img199040218_3.jpg GRAPHIC 61664
14 GRAPHIC img199040218_4.jpg GRAPHIC 121048
  Complete submission text file 0000950170-25-045731.txt   14225390

Data Files

Seq Description Document Type Size
15 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT svra-20241231.xsd EX-101.SCH 1733281
102 EXTRACTED XBRL INSTANCE DOCUMENT svra-20241231_htm.xml XML 2125679
Mailing Address 6836 BEE CAVE ROAD BUILDING 3, SUITE 201 AUSTIN TX 78746
Business Address 6836 BEE CAVE ROAD BUILDING 3, SUITE 201 AUSTIN TX 78746 51285113796
Savara Inc (Filer) CIK: 0001160308 (see all company filings)

EIN.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-32157 | Film No.: 25775306
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)